These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

323 related articles for article (PubMed ID: 11302287)

  • 1. Drug treatment options for irritable bowel syndrome: managing for success.
    Dunphy RC; Verne GN
    Drugs Aging; 2001; 18(3):201-11. PubMed ID: 11302287
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Management of irritable bowel syndrome: novel approaches to the pharmacology of gut motility.
    Scarpignato C; Pelosini I
    Can J Gastroenterol; 1999 Mar; 13 Suppl A():50A-65A. PubMed ID: 10202210
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Irritable bowel syndrome: new pharmaceutical approaches to treatment.
    Farthing MJ
    Baillieres Best Pract Res Clin Gastroenterol; 1999 Oct; 13(3):461-71. PubMed ID: 10580922
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Irritable bowel syndrome: new agents targeting serotonin receptor subtypes.
    De Ponti F; Tonini M
    Drugs; 2001; 61(3):317-32. PubMed ID: 11293643
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Irritable bowel syndrome: update on pathogenesis and management.
    Alaradi O; Barkin JS
    Med Princ Pract; 2002; 11(1):2-17. PubMed ID: 12116690
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of irritable bowel syndrome.
    Trinkley KE; Nahata MC
    J Clin Pharm Ther; 2011 Jun; 36(3):275-82. PubMed ID: 21545610
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Guidelines for the treatment of irritable bowel syndrome].
    Kwon JG; Park KS; Park JH; Park JM; Park CH; Lee KJ; Park HJ; Rhee JC;
    Korean J Gastroenterol; 2011 Feb; 57(2):82-99. PubMed ID: 21350320
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New developments in the treatment of irritable bowel syndrome.
    De Schryver AM; Samsom M
    Scand J Gastroenterol Suppl; 2000; (232):38-42. PubMed ID: 11232489
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Options for patients with irritable bowel syndrome: contrasting traditional and novel serotonergic therapies.
    Johanson JF
    Neurogastroenterol Motil; 2004 Dec; 16(6):701-11. PubMed ID: 15601419
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Peripherally acting therapies for the treatment of irritable bowel syndrome.
    Saad RJ
    Gastroenterol Clin North Am; 2011 Mar; 40(1):163-82. PubMed ID: 21333906
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Pharmacological treatment of the irritable bowel syndrome: a technical review].
    Remes-Troche JM; Gómez-Escudero O; Nogueira-de Rojas JR; Carmona-Sánchez R; Pérez-Manauta J; López-Colombo A; Sanjurjo-García JL; Noble-Lugo A; Chávez-Barrera JA; González-Martínez M
    Rev Gastroenterol Mex; 2010; 75(1):42-66. PubMed ID: 20423782
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of drug treatment in irritable bowel syndrome.
    Talley NJ
    Br J Clin Pharmacol; 2003 Oct; 56(4):362-9. PubMed ID: 12968980
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hypersensitivity and hyperreactivity in the irritable bowel syndrome: An opportunity for drug discovery.
    Sanger GJ
    Dig Dis; 1999; 17(2):90-9. PubMed ID: 10545714
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diagnostic and therapeutic strategies in the irritable bowel syndrome.
    Cremonini F; Talley NJ
    Minerva Med; 2004 Oct; 95(5):427-41. PubMed ID: 15467518
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Review article: clinical evidence to support current therapies of irritable bowel syndrome.
    Camilleri M
    Aliment Pharmacol Ther; 1999 May; 13 Suppl 2():48-53. PubMed ID: 10429740
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Irritable bowel syndrome: basis of clinical management strategies.
    Rosemore JG; Lacy BE
    J Clin Gastroenterol; 2002 Jul; 35(1 Suppl):S37-44. PubMed ID: 12184138
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The brain-gut axis in irritable bowel syndrome--clinical aspects.
    Mach T
    Med Sci Monit; 2004 Jun; 10(6):RA125-31. PubMed ID: 15173682
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Irritable bowel syndrome neuropharmacology. A review of approved and investigational compounds.
    Callahan MJ
    J Clin Gastroenterol; 2002 Jul; 35(1 Suppl):S58-67. PubMed ID: 12184141
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New drugs in the management of the irritable bowel syndrome.
    Farthing MJ
    Drugs; 1998 Jul; 56(1):11-21. PubMed ID: 9664195
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Irritable bowel syndrome: a concise diagnostic and pharmacological therapy review].
    Otero Regino W; Gómez Zuleta M
    Rev Gastroenterol Peru; 2005; 25(2):189-97. PubMed ID: 16021205
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.